ATHENAHEALTH INC Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q3 FY2015 As of Sep 30, 2015	Q2 FY2015 As of Jun 30, 2015	Q1 FY2015 As of Mar 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q3 FY2014 As of Sep 30, 2014	Q2 FY2014 As of Jun 30, 2014	Q1 FY2014 As of Mar 31, 2014	Q4 FY2013 As of Dec 31, 2013
Assets
Current assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Restricted cash
Deferred tax asset, net
Contract assets
Prepaid expenses and other current assets
Total current assets

Property and equipment, net
Capitalized software costs, net
Purchased intangible assets, net
Goodwill
Deferred tax assets
Deferred tax asset, net
Deferred tax assets, net
Investments and other assets
Other assets
Total assets

Liabilities & Stockholders’ Equity
Current liabilities:
Accounts payable
Accrued compensation
Accrued expenses
Line of credit
Current portion of long-term debt
Current portion of deferred rent
Deferred tax liability, net
Deferred revenue
Total current liabilities

Deferred rent, net of current portion
Line of credit
Long-term debt, net of current portion
Deferred tax liability, net
Deferred revenue, net of current portion
Other long-term liabilities
Total liabilities
Stockholders’ equity:
Preferred stock, $0.01 par value: 5.0 shares authorized; no shares issued and outstanding at September 30, 2018 and December 31, 2017
Common stock, $0.01 par value: 125.0 shares authorized; 40.6 shares issued and outstanding at September 30, 2018; 40.1 shares issued and outstanding at December 31, 2017
Additional paid-in capital
Treasury stock, at cost
Accumulated other comprehensive loss
Retained earnings
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments